Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes (Q47372990)

15 January 2018

title

Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes (English)

1 reference

15 January 2018

World Health Organization

main subject

1 reference

2

Nancy J Tarbell

1 reference

15 January 2018

author name string

Claire Y Fung

1

1 reference

15 January 2018

Mark J Lucarelli

3

1 reference

15 January 2018

Saveli I Goldberg

4

1 reference

15 January 2018

Rita M Linggood

5

1 reference

15 January 2018

Nancy L Harris

6

1 reference

15 January 2018

Judith A Ferry

7

1 reference

15 January 2018

language of work or name

English

0 references

publication date

1 December 2003

1 reference

15 January 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

15 January 2018

volume

57

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

page(s)

1382-1391

1 reference

15 January 2018

Occurrence and prognosis of extranodal lymphomas

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Primary radiotherapy for localized orbital MALT lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Radiation therapy of conjunctival and orbital lymphoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Orbital and conjunctival lymphoma treatment and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Conjunctival lymphoma: results and treatment with a single anterior electron field. A lens sparing approach

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

A new isoeffect curve for change in dose per fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Orbital lymphoma: radiotherapy outcome and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Radiotherapy in the management of orbital lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Radiotherapy of primary lymphoma of the orbit

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Primary orbital lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Radiation therapy for primary orbital lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Stage I and II MALT lymphoma: results of treatment with radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Detection of AP12-MALT1 chimaeric gene in extranodal and nodal marginal zone B-cell lymphoma by reverse transcription polymerase chain reaction (PCR) and genomic long and accurate PCR analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

t(11;18)(q21;q21) is the most common translocation in MALT lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900767-3

7 January 2021

10.1016/S0360-3016(03)00767-3

Identifiers

DOI

1 reference

15 January 2018

PubMed ID

14630277

1 reference

15 January 2018